Viromed Medical AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	0.36	0.02	0.2	0.15
Short-Term Investments	0	0	-	-
Cash & Short-Term Investments	0.36	0.02	0.2	0.15
Cash Growth	1391.16%	-87.50%	29.78%	-
Accounts Receivable	1.12	0.14	-	-
Total Trade Receivables	1.12	0.14	0	-
Other Current Assets	3.38	8.73	0.01	0
Total Current Assets	5.58	9.26	0.21	0.15
Net Property, Plant & Equipment	1.29	0.12	-	-
Other Intangible Assets	0.11	0.86	-	-
Goodwill	2.47	0	-	-
Long-Term Investments	0	0.01	20.1	20.1
Other Long-Term Assets	4.48	3.14	0.02	0
Total Assets	13.91	13.4	20.33	20.26
Accounts Payable	1.2	0.57	0.2	0.14
Accrued Expenses	0.4	0.34	0.03	0.03
Short-Term Debt	0.01	0.01	-	-
Other Current Liabilities	1.55	3.21	0.13	0
Total Current Liabilities	3.16	4.13	0.36	0.17
Long-Term Debt	0.28	0	-	-
Total Long-Term Liabilities	0.28	0	-	-
Total Liabilities	3.44	4.13	0.36	0.17
Common Stock	21.25	20.25	20.25	20.25
Treasury Stock	-0.04	-0.1	-	-
Additional Paid-in Capital	1.5	0	-	-
Retained Earnings	-12.23	-12.92	0.06	-0.16
Total Common Shareholders' Equity	10.47	7.22	20.31	20.09
Minority Interest	0	2.05	-	-
Shareholders' Equity	10.47	9.27	20.31	20.09
Total Liabilities & Equity	13.91	13.4	20.33	20.26
Total Debt	0.29	0.01	0	0
Net Cash (Debt)	0.07	0.01	0.2	0.15
Net Cash Growth	446.60%	-93.35%	29.78%	-
Net Cash Per Share	0.00	0.00	0.01	-
Book Value	10.47	7.22	20.31	20.09
Book Value Per Share	0.49	0.36	1.00	-
Tangible Book Value	7.89	6.36	20.31	20.09
Tangible Book Value Per Share	0.37	0.31	1.00	-